{
    "code": "52027709",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027709",
    "time": "2021-07-09 04:43:28",
    "許可證字號": "衛部藥輸字第027709號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/07\/18",
    "發證日期": "108\/07\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202770901",
    "中文品名": "&quot;比利時&quot;好度得注射液",
    "英文品名": "&quot;Belgium&quot; Haldol Decanoas",
    "適應症": "Haloperidol decanoate可持續治療目前使用口服haloperidol達到穩定狀態成人病人的思覺失調症及情感思覺失調症（schizoaffective disorder)",
    "劑型": "270注射劑",
    "包裝": "1ml (50mg)\/ Amp (Tubular Glass, type I) 每盒一百支以下",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "一般學名藥",
    "監視期限": "",
    "主成分略述": "HALOPERIDOL DECANOATE",
    "限制項目": "02輸　入",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號10樓及11樓",
    "主製造廠": [
        {
            "製造廠名稱": "FBE0009000  JANSSEN PHARMACEUTICA N.V.",
            "製造廠廠址": "TURNHOUTSEWEG 30, B-2340, BEERSE, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816100310",
            "成分名稱": "HALOPERIDOL DECANOATE",
            "含量描述": "(eq. to 50mg Haloperidol)",
            "含量": "70.5200000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "好度得注射液之外觀-108-10-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027709&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "比利時 好度得_仿單v1902_20190805-108-10-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027709&Seq=001&Type=9"
        },
        {
            "title": "比利時+好度得注射液1ml_標籤v02_20190827-108-10-08-109-11-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027709&Seq=004&Type=8"
        },
        {
            "title": "比利時+好度得注射液1ml_外盒v03_20190827-108-10-08-109-11-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027709&Seq=003&Type=8"
        },
        {
            "title": "比利時 好度得注射液1ml_標籤v02_20190827-108-10-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027709&Seq=002&Type=8"
        },
        {
            "title": "比利時 好度得注射液1ml_外盒v03_20190827-108-10-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027709&Seq=001&Type=8"
        }
    ]
}